Abstract | BACKGROUND: AIM: To evaluate the efficacy of rabeprazole 5 mg and 10 mg/day in Japanese NERD patients. The influence of baseline characteristics as well as genetic background on efficacy was also analysed. METHODS: Subjects were grade M (minimal changes) NERD patients. Two hundred and eighty-eight of these subjects, who were nonresponders to open label antacid therapy, entered in a 4-week, double-blind treatment (placebo, rabeprazole 5 mg or 10 mg/day). RESULTS: CONCLUSIONS:
Rabeprazole 5 mg was effective in a subgroup of Japanese NERD patients. Rabeprazole 10 mg provided more potent heartburn relief than 5 mg and was less fragile to baseline characteristics.
|
Authors | Y Kinoshita, K Ashida, M Hongo, Japan Rabeprazole Study Group for NERD |
Journal | Alimentary pharmacology & therapeutics
(Aliment Pharmacol Ther)
Vol. 33
Issue 2
Pg. 213-24
(Jan 2011)
ISSN: 1365-2036 [Electronic] England |
PMID | 21083596
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2010 Blackwell Publishing Ltd. |
Chemical References |
- 2-Pyridinylmethylsulfinylbenzimidazoles
- Proton Pump Inhibitors
- Rabeprazole
|
Topics |
- 2-Pyridinylmethylsulfinylbenzimidazoles
(administration & dosage, adverse effects)
- Adult
- Aged
- Aged, 80 and over
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Gastroesophageal Reflux
(drug therapy)
- Heartburn
(drug therapy)
- Humans
- Male
- Middle Aged
- Proton Pump Inhibitors
(administration & dosage, adverse effects)
- Rabeprazole
- Statistics as Topic
- Treatment Outcome
- Young Adult
|